Whether we are aware or not, diverse microorganisms are living on almost all environmentally exposed surfaces on our body without eliciting harmful immune responses. In fact, recent understanding from numerous studies indicates that our health is highly dependent on the contribution of intestinal commensal bacteria. It appears through its symbiotic interaction with the host, which is the result of millions of years of co-evolution, the microbiota shapes the immune system. In this review, we discuss the relationship between host physiology and commensal bacteria and explore the molecular mechanisms by which the adaptive immune system is influenced by the intestinal microbiota.
I. Introduction
Bacteria have inhabited Earth for two billion years and populated almost every location on our planet. Although we have a little knowledge of how indigenous microorganisms began associating with the animals, including humans, it seems that the bacterial community adapted to colonize nutrient-rich niches within the host. In turn, the microbial ecosystem has been established in mammals to help digest complex carbohydrates and provide essential nutrients to mammals. To thrive within the host, the microbiota have evolved to play an irreplaceable role in the host health for their mutual benefit. This relationship between microbiota and their host could be viewed by a term of symbiosis and the microbes are called as symbionts. In contrast, certain commensal microbes, while possibly providing some benefits to the host homeostatic conditions, may cause diseases under certain genetic and environmental conditions. These microbes have been termed as pathobionts (1, 2) . It is widely accepted that the microbiota contains a balanced composition of symbionts and pathobionts under normal
condition. An unnatural shift in the composition of the microbiota, called dysbiosis, was observed in many other diseases as well as autoimmune diseases (3) . Western societies display a decreased prevalence of many infectious diseases that is a result of improved hygienic practices as well as the development of antibiotics and vaccination.
Interestingly, there is obvious increase in the incidence of non-infectious immune disorders such as autoimmune diseases and allergic responses (4) . This inverse correlation implies that the environmental changes resulting in a disruption of commensal microbial communities may be a potential cause of dysregulation of immune system. The immune response is charged with the responsibility to distinguish between self and non-self. With the fact that numerous microorganisms are colonized on variable surfaces of the host, host immune system has been evolutionally forced to develop the ability to distinguish between commensal microbiota (considered as self) and pathogens. 
II. Understanding the human microbiota
We encounter the tremendously diverse microbial communities over the course of our lives starting with a birth. Immediately after birth, newborns are exposed to and rapidly colonized by microbes from the environment. The microbial diversity in the infant gut is initially very low and then is dramatically increased depending on dietary shift and differential exposed environment over the first few years of life (9) . Colonization and diversification occur within time in the various microbial habitats of the body and the differences in the microbiota composition exist among individuals (9) . It is thought that during this period the host immune system is learning to distinguish between commensal and pathogenic microbes. In adults, the stable microbiota are assembled depending on body surfaces and 
III. The microbiota in diseases-studies from model systems
Germ-free (GF) animals are born and raised in the absence of microbes, which allows for insights into the impact of the commensal microbiota on host health (14) . (18) . Therefore, the contribution of the microbiota to the development and function of the immune system appear to be fundamental.
In addition to its roles in the development of host immune responses, the intestinal microbiota influences on the development of many other disorders. Dysbiosis of gut microbial communities is observed in several diseases such as gastrointestinal diseases, obesity and autoimmune diseases (Fig. 1) . The compositional change of the gut microbiota was observed in patients with inflammatory bowel disease (IBD), although this change could be either the cause or the result of aberrant inflammation (13, 19) . It is widely accepted that human IBD is not caused by a specific pathogen, but by an immune system imbalance that is associated with gut dysbiosis. In animal studies, the transfer of microorganisms from IBD mice was sufficient to induce experimental IBD (20, 21) . Recent interesting studies have
shown that western-diet can be one of the inducing factors for dysbiosis. Dietary fat influences the composition and complexity of the gut microbiota by favoring the growth of a pathobiont, Bilophila wadsworthia (22) . It contributes to induce the development of inflammatory bowel disease in genetically susceptible animals (22) . Dysbiosis has been also implicated in the development of extra-intestinal disorders.
The altered composition of the gut microbiota, which leads (Fig. 2) (35~37) . The orally administrated SCFAs confer protection in T cell dependent colitis models (34, 35) .
Given the production of SCFAs by Clostiridia colonization was observed, it is highly possible that these bacteria might be using SCFAs-mediated mechanism to induction of Tregs in the intestine (35) . Intestinal bacterial metabolites and microbial components are an important communication tool between the host immune system and the microbiota to establish mutualism. (45) . SFB-mediated Th17 cell differentiation occurs through a mechanism independent of ATP signaling (45) (Fig. 2) . SFB-colonized 
Probiotics
The term probiotics is used to describe microorganisms that provide health benefits to host when consumed by diet. (49) . The administration of these probiotics has an effect on suppressing intestinal inflammation in several experimental colitis models (48, 49) . It seems that the probiotics also has protective effects on allergic responses in lungs and alleviates the symptom of atopic dermatitis in animal model, although these effects have not been demonstrated in human studies (50, 51) . Therefore, further studies to define molecular mechanism are required for medical practice or therapy.
V. Conclusions
We are just now beginning to understand the nature of our relationship with these microbes, making this an exciting time for human microbiota studies. These studies will include large scale techniques that are capable to do both basic biological studies and translational studies. More intensive investigations are now required to understand the interaction between microbiota and human health in many ways. The first step is the understanding stable and diverse microbial community within an individual through time and it can lead to identify personalized human microbiome.
The studies to understand the molecular mechanism of the microbiota to regulate host immune system are also needed.
These insights may enable the prediction of disease onset and progression and develop therapy, when the disturbance events such as diet shifts, antibiotic use, surgery, drug treatments or transplantations perturb the microbiota humanmicrobe relationship. It can lead to manipulate and reconstitution of the microbiota to re-establish healthy and stable microbial community.
